According to the report, the remote patient monitoring market is anticipated to grow from USD 26.1 Billion in 2024 to USD 88.3 Billion in 2035 at a CAGR of 11.7% during the forecast. Facilitated by demands for continuous, in-home care and advancements in smart medical devices, the remote patient monitoring (RPM) market is progressing rapidly across healthcare systems globally. For instance, recently Medtronic enhanced their HealthCast platform with wearable sensors that provide real-time tracking of patients' vital signs that alert physicians to identify health issues whenever they occur, and at distances well beyond the hospital. Conversely, GE HealthCare collaborated with local providers in India to pilot low-cost, app-connected RPM kits as foundational capabilities for chronic disease management in rural areas of the country.
As these illustrations denote, hospitals in the U.S. now leverage AI-powered remote patient monitoring tools, making it easier to track patients after discharge from surgery, or when long-term treatment is being performed at home eliminating the potential for readmission while relieving hospital staff of additional demand. Further, growth in the RPM marketplace has been supported by increased access to smartphones and the Internet around the world, as well as the health agency's resiliency in their efforts to continue to find ways to understand and sustain RPM.
Points of challenge still exist that include matters of data privacy, device costs, and issues of digital literacy to name a few, especially in historically and under-represented communities, but work is being done to improve the circumstances of access to technology, the training of individuals to use the devices, and the development of a continuum for RPM in health systems more broadly in hopes of sustaining RPM as a viable option to facilitate timely care and personalized care away from the hospital walls, where appropriate.
Remote Patient Monitoring (RPM) is being adopted progressively fast due in part to the demands of value-based care and the management of chronic conditions outside institutional or hospital-based systems. As we see increases in the aging population and chronic conditions such as diabetes, hypertension, and heart disease on rise across our population, health systems began to deploy RPM to track patients’ vitals in real time so they can intervene early and minimize the risk of readmissions. RPM is innovating in the realm of connected health with organizations like Philips, Medtronic, and Dexcom boldly spearheading the research and development of usable, commercially credible biosensors for wearables, cloud-based monitoring systems, dashboards, and AI powered analytics. In conjunction, these systems allow healthcare providers, clinical staff and others to make decisions sooner to manage patient improvement and mitigation while keeping patient costs lower overall.
There have been significant advancements in technology, and yet there remain many barriers to broad adoption of RPM solutions. The initial costs can be high and integration of the required hardware and software can be complicated. Cyber security is an ongoing issue for smaller providers and resource-limited settings. Furthermore, compliance by patients with home or wearable monitoring is frequently challenged by device fatigue, lack of digital literacy or lack of faith in remote care. Additional regulatory barriers vary from region to region and stifle cross-border mobilization of RPM services and potential for scale.
RPM market holds immense promise with emerging 5G, artificial intelligence, and smart technology for more efficient, at-home health monitoring. Government agencies, insurance benefits, and affordable tools have made more RPM accessible to patients, especially in rural areas. The combination of RPM, telehealth, and digital health records will have many positive impacts on how healthcare is delivered in a connected, efficient manner.
The remote patient monitoring (RPM) market is increasingly feeling the impacts of rising global tariff regulations in the digital health ecosystem that are no longer limited to traditional medical devices. RPM systems rely on an asset- and logistics-heavy supply chain, consisting of imported sensors, wearable health trackers, Bluetooth-connected devices, and cloud-based analytic and data management platforms. Tariffs on all of the imported components inflate the overall production and deployment costs.
Markets like Southeast Asia, Latin America, and Africa where healthcare systems have generally been poorly funded, face even higher barriers. Import duties on important RPM devices like batteries and semiconductors or on networking tools like ports or gateways cause prices to rise and render RPM adoption considerably less achievable for community health centers and similarly-sized providers. This presents a specific dilemma in chronic disease care with long-term patient monitoring that is cost-sensitive.
In addition to traditional tariffs there are taxes on digital services and data localization laws in places like the EU and India. This forms additional operational burdens on multinational RPM providers for horizontal operations and also restricts centralized and therefore efficient data management. These tax, tariff, and regulation burdens can slow product launches resulting in service fragmentation and limited scalability.
Prominent players operating in the remote patient monitoring market include Abbott Laboratories, AMD Global Remote patient monitoring , Biofourmis, Inc., Biotelemetry, Inc. (a Philips company), Boston Scientific Corporation, Dexcom, Inc., G Medical Innovations, GE HealthCare, Hill-Rom Holdings, Inc., Honeywell Life Sciences, iRhythm Technologies, Inc., Masimo Corporation, Medtronic plc, Nihon Kohden Corporation, Omron Healthcare, Inc., Philips Healthcare, ResMed Inc., Tunstall Healthcare Group, VitalConnect, Inc., VivaLNK, Inc., and Other key Players.
MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.
800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.
+1(302)303-2617
info@marketgenics.co
3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.
sales@marketgenics.co
Table of Contents
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography
We will customise the research for you, in case the report listed above does not meet your requirements.
Get 10% Free Customisation